Original gonadorelin is a synthetic decapeptide structural duplicate of native hypothalamic gonadotropin-releasing hormone (GnRH). Designed exclusively for in vitro and preclinical research applications, this un-modified peptide provides investigators with a precise molecular tool for evaluating pituitary receptor activation, gonadotropin expression, and reproductive endocrinology pathways.
Original gonadorelin is a synthetic decapeptide structural duplicate of native hypothalamic gonadotropin-releasing hormone (GnRH). Designed exclusively for in vitro and preclinical research applications, this un-modified peptide provides investigators with a precise molecular tool for evaluating pituitary receptor activation, gonadotropin expression, and reproductive endocrinology pathways.
Original gonadorelin is a synthetic decapeptide identical in amino acid sequence (pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2) to endogenous gonadotropin-releasing hormone (GnRH). Designed strictly for laboratory research, it serves as a primary reference tool to study hypothalamic-pituitary-gonadal (HPG) axis activation, pulsatile receptor signaling, and downstream luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion in cellular and animal models.
Unlike modified GnRH agonists that incorporate synthetic D-amino acid substitutions or C-terminal ethylamide modifications to prolong biological half-life, original gonadorelin preserves the native, native-sequence decapeptide structure. In laboratory assays, this unmodified configuration exhibits the classic rapid receptor binding kinetics and short biological half-life observed in mammalian neuroendocrine systems. Researchers frequently utilize this exact sequence when baseline physiological kinetics or reversible receptor interaction profiles are required, as detailed across the PX1 research library hub.
Because of its identical molecular architecture to hypothalamic GnRH, original gonadorelin serves as the gold standard control in comparative receptor-binding assays, signal transduction research, and down-regulation studies across preclinical research facilities.
The chemical structure of original gonadorelin consists of ten amino acid residues featuring a pyroglutamyl residue at the N-terminus and a carboxamide group at the C-terminus. Its chemical formula is expressed as C55H75N17O13, with a exact molecular weight of approximately 1182.3 g/mol. Both the N-terminal cyclization and C-terminal amidation are essential structural parameters required for high-affinity binding to the GnRH receptor (GnRHR).
In analytical chemistry workflows, verifying the precise primary sequence is necessary to confirm that the compound has not undergone unwanted degradation, such as deamidation or peptide cleavage. When evaluating all peptides within the hypothalamic signaling class, maintaining sequence fidelity is paramount for reproducible experimental outcomes.
Due to the absence of sterically hindering side chains or non-natural amino acids, original gonadorelin exhibits standard enzymatic susceptibility when exposed to neutral endopeptidases and post-proline cleaving enzymes in biological matrices. This inherent susceptibility makes it an ideal reference molecule for investigating enzymatic degradation rates in preclinical neuroendocrine experiments.
In vitro and preclinical models demonstrate that original gonadorelin selectively binds to high-affinity, seven-transmembrane G-protein coupled receptors (GPCRs) located on the plasma membrane of anterior pituitary gonadotrope cells. Binding initiates a conformational change that activates the Gq/11 protein complex, triggering downstream activation of phospholipase C (PLC).
Phospholipase C hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) into two major intracellular secondary messengers: inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). IP3 interacts with specific receptor channels on the endoplasmic reticulum to induce rapid intracellular calcium mobilization. Concurrently, DAG activates protein kinase C (PKC) cascades, leading to the phosphorylation of mitogen-activated protein kinases (MAPK).
Preclinical data indicate that these convergent signaling cascades drive both the exocytosis of pre-stored gonadotropins (LH and FSH) and the transcriptional upregulation of gonadotropin subunit genes. Investigators measuring pulsatile stimulation observe that intermittent exposure to original gonadorelin maintains signaling responsiveness, whereas continuous exposure induces receptor desensitization and down-regulation—a key cellular mechanism studied extensively in reproductive physiology.
In vitro research using primary pituitary cell cultures and immortalized gonadotrope cell lines relies heavily on original gonadorelin to characterize receptor-ligand interaction dynamics. Studies examining receptor internalization kinetics reveal that the native sequence undergoes rapid endocytosis following ligand binding, followed by sorting pathways that either recycle the receptor to the cell surface or direct it toward lysosomal degradation.
In rodent models, researchers utilize original gonadorelin to establish baseline sensitivity benchmarks for the hypothalamic-pituitary axis. These animal studies frequently measure time-dependent plasma gonadotropin spikes following acute administration, establishing dose-response parameters without the prolonged receptor occupancy characteristic of synthetic analogs.
Furthermore, in vitro assays investigating cross-talk between the HPG axis and peripheral endocrine signaling pathways utilize original gonadorelin as a clean agonist to observe isolated intracellular responses without confounding long-acting metabolic accumulation.
When designing neuroendocrine research models, selecting the appropriate agonist configuration is critical. Original gonadorelin represents the unmodified native sequence, characterized by a rapid clearance profile and brief receptor occupancy time. In contrast, modified GnRH agonists such as triptorelin and leuprolide incorporate structural modifications designed to enhance enzymatic resistance and receptor affinity.
For example, replacing the native glycine at position 6 with a D-amino acid (as seen in triptorelin and leuprolide) or modifying the C-terminal glycinamide sequence alters the peptide's tertiary conformation. These structural alterations reduce enzymatic cleavage by peptidases, yielding a half-life significantly longer than that of original gonadorelin. Comparative studies involving buserelin further demonstrate how specific substitutions alter the duration of receptor occupancy and subsequent desensitization thresholds.
While extended-release or modified analogs are utilized when sustained receptor saturation is desired, original gonadorelin remains the standard choice for researchers modeling rapid, pulsatile neuroendocrine pulses or investigating baseline receptor kinetics in un-modified states.
To preserve peptide integrity during laboratory preparation, lyophilized original gonadorelin must be reconstituted following rigorous sterile techniques. Reconstitution should occur using a sterile, non-pyrogenic diluent such as laboratory-grade bacteriostatic water or sterile standard saline, depending on the requirements of the specific cell culture or assay protocol.
When introducing the solvent to the lyophilized cake, the diluent should be directed gently down the glass inner wall of the vial rather than sprayed directly onto the peptide powder. The vial should be gently swirled or rolled between the palms until complete dissolution is observed. Violent mechanical agitation, such as vortexing, must be strictly avoided, as shear forces can induce peptide aggregation or structural denaturation.
All reconstitution procedures should take place within a certified laminar flow hood utilizing sterile pipettes and non-pyrogenic laboratory consumables to prevent microbial contamination or introduction of trace environmental interfering agents.
Lyophilized original gonadorelin demonstrates high chemical stability when stored in desiccated conditions protected from light at temperatures of -20°C or below. Under these baseline storage conditions, the peptide maintains structural fidelity and prevents hydrolysis or oxidative degradation over extended research timeframes.
Following reconstitution, liquid peptide solutions exhibit reduced stability over time. To minimize degradation pathways such as peptide bond cleavage or deamidation, reconstituted solutions should be stored at 2°C to 8°C for short-term experimental windows. For extended usage, reconstituted solutions must be divided into single-use experimental aliquots and frozen at -20°C or -80°C.
Repeated freeze-thaw cycles must be rigorously avoided, as ice crystal formation subjects the peptide backbone to physical stress, leading to irreversible loss of functional purity and potential aggregation.
Reliable scientific outcomes depend on the chemical purity and consistency of research reagents. When sourcing original gonadorelin, laboratory investigators must evaluate suppliers based on comprehensive analytical verification standards rather than unverified product claims.
Essential quality standards include lot-specific documentation via a Certificate of Analysis (COA) containing Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) chromatograms to confirm physical purity (target >98%) and Electrospray Ionization Mass Spectrometry (ESI-MS) spectrum data to confirm exact molecular weight match. Furthermore, bacterial endotoxin testing via Limulus Amebocyte Lysate (LAL) assays must confirm endotoxin levels below stringent thresholds (<0.05 EU/mg) to prevent confounding inflammatory responses in cell culture or animal models.
Researchers managing larger facility demands or established institutional studies often collaborate with dedicated supplier channels via wholesale lab accounts to ensure lot traceability, consistent batch manufacturing, and secured supply chains.
PX1 Research is an established USA-based supplier dedicated exclusively to providing research-grade peptides for laboratory investigation. Every lot of original gonadorelin supplied by PX1 Research is manufactured in state-of-the-art facilities operating in compliance with GMP guidelines and ISO 17025 laboratory testing standards.
To ensure uncompromising research integrity, every single production lot undergoes independent, third-party analytical verification. Researchers receive lot-traceable COAs documenting RP-HPLC purity profiles, mass spectrometry identification, and verified endotoxin parameters prior to experimental deployment.
Orders fulfilled through PX1 Research are dispatched directly from our CA and AZ distribution centers with same-day shipping for qualifying orders placed Monday through Friday. This ensures rapid transit times and preserves chain-of-custody standards required for sensitive research compounds.
What is original gonadorelin in a laboratory setting?
Original gonadorelin is a synthetic decapeptide identical in amino acid sequence to native hypothalamic gonadotropin-releasing hormone (GnRH). It is strictly used in preclinical and in vitro research to investigate HPG axis signaling and gonadotropin dynamics.
How does original gonadorelin differ from modified GnRH analogs?
Unlike modified analogs such as triptorelin or leuprolide, original gonadorelin contains no synthetic amino acid substitutions. Consequently, it maintains native binding kinetics and a brief biological half-life, whereas modified analogs exhibit enhanced enzymatic resistance and prolonged receptor occupancy.
What analytical tests verify the purity of original gonadorelin?
Purity is verified using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to assess chemical purity (>98%) and Electrospray Ionization Mass Spectrometry (ESI-MS) to confirm exact molecular mass. Endotoxin levels are quantified using LAL testing.
How should lyophilized original gonadorelin be stored upon receipt?
Lyophilized original gonadorelin should be stored desiccated, protected from light, at or below -20°C. Long-term storage under these conditions preserves peptide integrity and prevents hydrolysis.
What is the recommended method for reconstituting original gonadorelin for lab use?
Reconstitute using sterile, non-pyrogenic laboratory solvent (such as bacteriostatic water) by gently allowing the liquid to run down the inner vial wall. Gently swirl until dissolved; do not vortex or agitate vigorously.
Why is endotoxin testing critical for original gonadorelin research?
Bacterial endotoxins can stimulate inflammatory pathways in cell cultures and animal models, confounding experimental data regarding cellular signaling, cytokine expression, and baseline endocrine release.
What receptors does original gonadorelin target in cell culture models?
Original gonadorelin selectively binds to the high-affinity GnRH receptor (GnRHR), a G-protein coupled receptor located on anterior pituitary gonadotrope cells.
Does PX1 Research provide lot-specific COAs for original gonadorelin?
Yes. Every lot of original gonadorelin supplied by PX1 Research includes a third-party Certificate of Analysis confirming RP-HPLC purity, ESI-MS mass identification, and LAL endotoxin data.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.